Lv51
1590 积分 2023-03-27 加入
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL)
11天前
已完结
A Phase I trial of BI 1810631, a HER2 tyrosine kinase inhibitor (TKI), as monotherapy in patients (pts) with advanced/metastatic solid tumors with HER2 aberrations
27天前
已完结
Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer
28天前
已完结
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
28天前
已完结
Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial
28天前
已完结
Nickel‐Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers**
30天前
已完结
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations
1个月前
已完结
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood–Brain Barrier: The Discovery of AZD1390
1个月前
已完结
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
1个月前
已完结
Recent progress on tyrosine kinase 2 JH2 inhibitors
1个月前
已完结
皖公网安备34019202002308
